Troyanov Stéphan, Delmas-Frenette Catherine, Bollée Guillaume, Youhanna Sonia, Bruat Vanessa, Awadalla Philip, Devuyst Olivier, Madore François
Nephrology Division, Sacré-Coeur Hospital, Montreal, Quebec, Canada;
Nephrology Division, Hospital Center for the University of Montreal (CHUM), Montreal, Quebec, Canada;
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):62-9. doi: 10.2215/CJN.04770415. Epub 2015 Dec 18.
The urinary excretion of uromodulin is influenced by common variants in the UMOD gene, and it may be related to NaCl retention and hypertension. Levels of uromodulin are also dependent of the renal function, but other determinants remain unknown.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We tested associations between the urinary excretion of uromodulin; medical history and medication; serum and urinary levels of electrolytes, glucose, and uric acid; and the genotype at the UMOD/Protein Disulfide Isomerase-Like, Testis Expressed locus (rs4293393 and rs12446492); 943 participants from the CARTaGENE Cohort, a random sample from the Canadian population of 20,004 individuals, were analyzed. Participants with available genotyping were obtained from a substudy addressing associations between common variants and cardiovascular disease in paired participants with high and low Framingham risk scores and vascular rigidity indexes.
The population studied was 54±9 years old, with 51% women and eGFR of 9±14 ml/min per 1.73 m(2). Uromodulin excretion was 25 (11-42) mg/g creatinine. Using linear regression, it was independently higher among patients with higher eGFR, the TT genotype of rs4293393, and the TT genotype of rs12446492. The fractional excretions of urate and sodium showed a strong positive correlation with uromodulin, likely linked to the extracellular volume status. The presence of glycosuria and the use of uricosuric drugs, which both increased the fraction excretion of urate, were independently associated with a lower uromodulin excretion, suggesting novel interactions between uric acid and uromodulin excretion.
In this large cohort, the excretion of uromodulin correlates with clinical, genetic, and urinary factors. The strongest associations were between uric acid, sodium, and uromodulin excretions and are likely linked to the extracellular volume status.
尿调节蛋白的尿排泄受UMOD基因常见变异的影响,且可能与氯化钠潴留和高血压有关。尿调节蛋白水平也取决于肾功能,但其他决定因素尚不清楚。
设计、地点、参与者与测量方法:我们测试了尿调节蛋白的尿排泄;病史和用药情况;血清和尿液中的电解质、葡萄糖和尿酸水平;以及UMOD/蛋白二硫键异构酶样、睾丸表达位点(rs4293393和rs12446492)的基因型之间的关联;对来自CARTaGENE队列的943名参与者进行了分析,该队列是从20,004名加拿大人群中随机抽取的样本。具有可用基因分型的参与者来自一项子研究,该子研究探讨了在弗明汉风险评分和血管硬度指数高低配对的参与者中常见变异与心血管疾病之间的关联。
所研究的人群年龄为54±9岁,女性占51%,估算肾小球滤过率为每1.73平方米9±14毫升/分钟。尿调节蛋白排泄量为25(11 - 42)毫克/克肌酐。使用线性回归分析,在估算肾小球滤过率较高的患者、rs4293393的TT基因型患者以及rs12446492的TT基因型患者中,尿调节蛋白排泄量独立地更高。尿酸和钠的分数排泄与尿调节蛋白呈强正相关,可能与细胞外液量状态有关。糖尿的存在和使用促尿酸排泄药物均增加了尿酸的分数排泄,且与较低的尿调节蛋白排泄独立相关,提示尿酸与尿调节蛋白排泄之间存在新的相互作用。
在这个大型队列中,尿调节蛋白的排泄与临床、遗传和尿液因素相关。最强的关联存在于尿酸、钠和尿调节蛋白排泄之间,且可能与细胞外液量状态有关。